Literature DB >> 30848793

Individuals With Prediabetes Display Different Age-Related Pathophysiological Characteristics.

Teresa Vanessa Fiorentino1, Elisabetta Pedace1, Elena Succurro1, Francesco Andreozzi1, Maria Perticone2, Angela Sciacqua1, Francesco Perticone1, Giorgio Sesti1.   

Abstract

CONTEXT: Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are highly pathophysiologic heterogeneous prediabetes conditions that can occur in all age groups, from youth to elderly people.
OBJECTIVE: We evaluated whether distinct age-related phenotypes exist among individuals with IFG or IGT. RESEARCH
DESIGN: 479 young (aged 18 to 35 years), 699 adult (45 to 55 years) and 240 older (≥65 years) subjects underwent an oral glucose tolerance test (OGTT). From the OGTT results, the participants were grouped as follows: young age and normal glucose tolerance (NGT), adult age and NGT, older age and NGT, IFG young subjects, IFG adult subjects, IFG older subjects, IGT young (Y-IGT) subjects, IGT adult (A-IGT) subjects, and IGT older (O-IGT) subjects. MAIN OUTCOME MEASURES: Insulin sensitivity and secretion, insulin clearance, and β-cell function.
RESULTS: Peripheral insulin sensitivity assessed using the Matsuda index, basal and glucose-stimulated insulin secretion, and β-cell function estimated using the disposition index were decreased in IFG adult subjects and IFG older subjects compared with IFG young subjects. A-IGT and Y-IGT subjects exhibited a progressively greater degree of hepatic insulin resistance assessed using the liver insulin resistance index, and reduced insulin clearance compared with O-IGT subjects. In contrast, the Matsuda index did not differ among Y-IGT, A-IGT, and O-IGT subjects. Basal and glucose-stimulated insulin secretion and β-cell function were lower in A-IGT and O-IGT subjects compared with Y-IGT individuals.
CONCLUSIONS: Subjects with IFG or IGT exhibited different age-related pathophysiologic characteristics. A more precise phenotyping of subjects with IGT or IFG could help to better design individualized preventive approaches to counteract diabetes progression.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30848793     DOI: 10.1210/jc.2018-02610

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  1 in total

1.  Obstructive Sleep Apnea Exacerbates Glucose Dysmetabolism and Pancreatic β-Cell Dysfunction in Overweight and Obese Nondiabetic Young Adults.

Authors:  Ning Li; Yun Fan; Jian Ping Zhou; Ocholi Don Maimba; Liu Zhang; Qing Yun Li
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-10       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.